086900 — Medy Tox Income Statement
0.000.00%
- KR₩1tn
- KR₩1tn
- KR₩221bn
- 72
- 11
- 23
- 24
Annual income statement for Medy Tox, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 205,900 | 140,828 | 184,870 | 195,096 | 221,121 |
Cost of Revenue | |||||
Gross Profit | 136,370 | 74,341 | 105,853 | 126,405 | 133,871 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 182,984 | 182,279 | 54,520 | 154,250 | 196,864 |
Operating Profit | 22,916 | -41,452 | 130,349 | 40,846 | 24,257 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25,150 | -42,139 | 128,265 | 49,526 | 15,853 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25,563 | -30,039 | 93,263 | 36,596 | 9,690 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26,206 | -29,577 | 94,154 | 37,010 | 9,755 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 26,206 | -29,577 | 93,179 | 36,035 | 8,780 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4,406 | -4,172 | 3,825 | 6,170 | 739 |
Dividends per Share |